Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(1119/week)
    • Manufacturing(567/week)
    • Technology(1121/week)
    • Energy(438/week)
    • Other Manufacturing(383/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

Novartis Group Companies

Dec 01, 2018
Novartis announces new crizanlizumab (SEG101) data analysis in sickle cell disease, and investment in SENTRY clinical program
Oct 02, 2018
Alcon introduces enhanced WaveLight® Refractive Suite to optimize the patient and surgeon LASIK experience
Aug 02, 2018
Novartis announces US renewables agreement to reduce greenhouse gas emissions
Jul 20, 2018
Alcon introduces NGENUITY® 3D Visualization System with DATAFUSION(TM) to simplify, customize vitreoretinal surgery
Jul 18, 2018
Novartis Kisqali® now first and only CDK4/6 inhibitor indicated in US as first-line therapy specifically for premenopausal women; and as initial therapy with fulvestrant in postmenopausal women
Jul 12, 2018
Novartis launches the Galaxies of Hope app, a digital experience for the Neuroendocrine Tumor (NET) cancer community
Jul 06, 2018
Sandoz Inc. and its affiliate, Novartis Pharmaceuticals Corporation, voluntarily recall select blister packages of products in the U.S. due to packaging requirements for child resistance
Jun 27, 2018
Novartis announces funding for patient advocacy initiatives to support and empower metastatic breast cancer community
Jun 19, 2018
Novartis receives FDA approval for inclusion of new evidence that Cosentyx® inhibits progression of joint structural damage in psoriatic arthritis
Jun 16, 2018
Novartis JULIET trial of Kymriah demonstrates more than one-year durability of responses in adults with relapsed or refractory DLBCL
Jun 15, 2018
Novartis survey uncovers real-world impact of immune thrombocytopenia or ITP, a rare blood disease, on patients' quality of life
Jun 03, 2018
Third Novartis Phase III trial shows Kisqali® combination therapy significantly improves PFS in HR+/HER2- advanced breast cancer
Jun 02, 2018
New Novartis data presented at ASCO find nearly half of CML patients treated with Tasigna® remain in remission almost three years after stopping therapy
May 30, 2018
FDA expedites review of Novartis drug Promacta® for first-line severe aplastic anemia (SAA)
May 17, 2018
Novartis data at ASCO and EHA reinforce company's commitment to reimagining cancer
May 11, 2018
Novartis announces FDA approval of Gilenya® as the first disease-modifying therapy for pediatric relapsing multiple sclerosis
May 01, 2018
Kymriah® (tisagenlecleucel), first-in-class CAR-T therapy from Novartis, receives second FDA approval to treat appropriate r/r patients with large B-cell lymphoma
Apr 30, 2018
Novartis receives FDA approval of Tafinlar® + Mekinist® for adjuvant treatment of BRAF V600-mutant melanoma
Apr 25, 2018
Novartis launches FocalView app, providing opportunity for patients to participate in ophthalmology clinical trials from home
Apr 10, 2018
Novartis drug Afinitor DISPERZ® receives FDA approval to treat TSC-associated partial-onset seizures
  •  
  • Page 1
  • ››

Latest News

Sep 25, 2025

Keysight to Demonstrate AI-enabled 6G and Wireless Technologies at India Mobile Congress 2025

Sep 25, 2025

Element U.S. Space & Defense Facilitates Weaponized UUV Testing in Rustburg, VA to Accelerate Mission-...

Sep 24, 2025

Lessen Releases First-Ever Repair & Maintenance Benchmark Report, Setting a New Standard for the Single-...

Sep 24, 2025

Power Insights Publishes 2025 North American Electric Transmission & Distribution Market Forecasts

Sep 24, 2025

PAC Worldwide Unrolls Sustainable Packaging Innovations at PACK EXPO 2025

Sep 24, 2025

LevelBlue Research Finds Rising Cyber Threats to Manufacturing Are Driving Leaders to Prioritize Cyber...

Sep 24, 2025

Textron to Release Third Quarter Results on October 23, 2025

Sep 24, 2025

New Energy Risk Announces First Tax Credit Insurance Transaction

View all News

Agenda

27
January
United States of AmericaThe Westin Arlington, Arlington, VA
Future Indirect Fires, January 27-28, 2026, The Westin Arlington, Arlington, VA
Future Indirect Fires, January 27-28, 2026, The Westin Arlington, Arlington, VA Supporting Next-Generation Capability...
03
December
United Kingdom Copthorne Tara Hotel, London, UK
Uncrewed & Autonomous Systems, 3 - 4 December 2025, Copthorne Tara Hotel, London, UK
Uncrewed & Autonomous Systems | 3 - 4 December 2025| Copthorne Tara Hotel, London, UK   Uncrewed & Autonomous...
28
October
Copthorne Tara Hotel, London, UK
Maritime ISR, 28-29 October 2025, Copthorne Tara Hotel, London, UK
Maritime ISR | 28-29 October 2025 | Copthorne Tara Hotel, London, UK   This year’s conference brings together senior...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia